Intercept Pharmaceuticals | Spese Operative



Operating Expenses Cambiamento Data
Acadia Pharmaceuticals USD 225.03M 118.93M 2025-03
Alnylam Pharmaceuticals USD 576.11M 122.21M 2025-03
Amarin USD 58.77M 56.06M 2025-03
Amgen USD 6.86B 85M 2025-03
Arrowhead Research USD 161.51M 2.4M 2025-03
AstraZeneca USD 9.91B 2.94B 2025-03
Biogen USD 2.12B 106.5M 2025-03
Bristol-Myers Squibb USD 8.23B 3.32B 2025-03
Eli Lilly USD 7.32B 1.06B 2025-03
Gilead Sciences USD 4.43B 687M 2025-03
GlaxoSmithKline GBP 5.3B 2.12B 2025-03
Incyte USD 847.73M 29.46M 2025-03
Ionis Pharmaceuticals USD 278M 59.4M 2025-03
Moderna USD 1.16B 1.06B 2025-03
Neurocrine Biosciences USD 485.7M 47.4M 2024-12
Novartis USD 11.28B 1.73B 2024-12
PTC Therapeutics USD 205.87M 69.79M 2025-03
Regeneron Pharmaceuticals USD 2.44B 362M 2025-03
Sarepta Therapeutics USD 1.05B 548.51M 2025-03
Vertex Pharmaceuticals USD 1.89B 230.4M 2024-12



Intercept Pharmaceuticals Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.